Mesothelioma and Non-Toxic Therapies Curcumin and Bromelain

Share Button

Curcumin and Bromelain have been shown to both kill mesothelioma as well as enhance the efficacy of conventional chemotherapy to kill meso. 

As a long-term survivor of an “incurable” cancer, multiple myeloma, I’ve learned that it is conventional oncology that refers to a cancer as being incurable only if conventional oncology cannot cure the cancer. In other words, the many therapies that I have taken to keep me cancer-free since 1999 are considered non-conventional or not approved by the Food and Drug Administration. Yet these therapies are effective cancer therapy.

Image result for image of mesothelioma

 It’s clear from the studies linked and excerpted below that reducing inflammation with curcumin and bromelain help meso patients live longer.

Curcumin  and Bromelain are both evidenced-based non-conventional therapies that fight both myeloma and meso. I supplement with Life Extension Super Bio-Curcumin and also with an enzyme combo called Wobenzyme N. The link below explains the what and why of curcumin therapy. Wobenzym N is the systemic enzyme that I take that contains bromelain.

I am both a cancer survivor and cancer coach. Experience and research have taught me that cancer patients and survivors must use both conventional (FDA approved) and evidence-based non-conventional therapies to beat their cancers.

If you have any questions about other non-conventional or conventional therapies for mesothelioma scroll down the page, post a question or comment and I will reply ASAP.

Thank you,

David Emerson

  • Cancer Survivor
  • Cancer Coach
  • Director PeopleBeatingCancer

Bromelain and curcumin as integrative mesothelioma cancer therapy

“Curcumin and an enzyme called bromelain are two such integrative therapies. By themselves they fight mesothelioma. Combined with conventional chemo they fight mesothelioma….”

Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma.

“Malignant peritoneal mesothelioma (MPM) expresses MUC1 and initial studies have shown that the viability of MPM cells is adversely affected by exposure to bromelain. Further, bromelain in combination with either 5-FU or cisplatin, the efficacy of the chemotherapeutic drug is enhanced. Hence, current evidence indicates that bromelain may have the potential of being developed into an effective anticancer agent for MPM.”



Leave a Comment: